Amod A Sarnaik (Amod Sarnaik)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Acute Myeloid Leukemia

Top Venues

Journal for immunotherapy of cancer

Molecular cancer therapeutics

Journal of immunology (Baltimore, Md. : 1950)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular cancer therapeutics 23 (8) (2024)
Allison Betof Warner, Omid Hamid, Krishna Komanduri, Rodabe Amaria, Marcus O Butler, John B A G Haanen, Sarah Nikiforow, Igor Puzanov, Amod A Sarnaik, Michael R Bishop, Adam J Schoenfeld
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy. Journal for immunotherapy of cancer 12 (2) (2024)
Zachary Z Reinstein, Yue Zhang, Oscar E Ospina, Matt D Nichols, Victoria A Chu, Alvaro de Mingo Pulido, Karol Prieto, Jonathan V Nguyen, Rui Yin, Carlos Moran Segura, Ahmed Usman, Brittney R Sell, Spencer Ng, Janis V de la Iglesia, Sunandana Chandra, Jeffrey A Sosman, Raymond J Cho, Jeffrey B Cheng, Ellie N Ivanova, Sergei B Koralov, Robbert J C Slebos, Christine H Chung, Nikhil I Khushalani, Jane L Messina, Amod A Sarnaik, Jonathan S Zager, Vernon K Sondak, Charles J Vaske, Sungjune Kim, Andrew S Brohl, Xinlei Mi, Brian G Pierce, Xuefeng Wang, Brooke L Fridley, Kenneth Y Tsai, Jaehyuk Choi
Pre-existing skin-resident CD8 and gd T cell circuits mediate immune response in Merkel cell carcinoma and predict immunotherapy efficacy. Cancer discovery (2024)
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular cancer therapeutics 23 (8) (2024)
Allison Betof Warner, Omid Hamid, Krishna Komanduri, Rodabe Amaria, Marcus O Butler, John B A G Haanen, Sarah Nikiforow, Igor Puzanov, Amod A Sarnaik, Michael R Bishop, Adam J Schoenfeld
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy. Journal for immunotherapy of cancer 12 (2) (2024)
Allison Betof Warner, Omid Hamid, Krishna Komanduri, Rodabe Amaria, Marcus O Butler, John B A G Haanen, Sarah Nikiforow, Igor Puzanov, Amod A Sarnaik, Michael R Bishop, Adam J Schoenfeld
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy. Journal for immunotherapy of cancer 12 (2) (2024)
Allison Betof Warner, Omid Hamid, Krishna Komanduri, Rodabe Amaria, Marcus O Butler, John B A G Haanen, Sarah Nikiforow, Igor Puzanov, Amod A Sarnaik, Michael R Bishop, Adam J Schoenfeld
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy. Journal for immunotherapy of cancer 12 (2) (2024)
Allison Betof Warner, Omid Hamid, Krishna Komanduri, Rodabe Amaria, Marcus O Butler, John B A G Haanen, Sarah Nikiforow, Igor Puzanov, Amod A Sarnaik, Michael R Bishop, Adam J Schoenfeld
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy. Journal for immunotherapy of cancer 12 (2) (2024)
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-human stage III/IV melanoma clinical trial of immune priming agent IFx-Hu2.0. Molecular cancer therapeutics (2024)
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular cancer therapeutics 23 (8) (2024)
Jason Chesney, Karl D Lewis, Harriet Kluger, Omid Hamid, Eric D Whitman, Sajeve Thomas, Martin Wermke, Mike Cusnir, Evidio Domingo-Musibay, Giao Q Phan, John M Kirkwood, Jessica C Hassel, Marlana Orloff, James Larkin, Jeffrey S Weber, Andrew J S Furness, Nikhil I Khushalani, Theresa Medina, Michael E Egger, Friedrich Graf Finckenstein, Madan Jagasia, Parameswaran Hari, Giri Sulur, Wen Shi, Xiao Wu, Amod A Sarnaik
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study. Journal for immunotherapy of cancer 10 (12) (2023)
Jason Chesney, Karl D Lewis, Harriet Kluger, Omid Hamid, Eric D Whitman, Sajeve Thomas, Martin Wermke, Mike Cusnir, Evidio Domingo-Musibay, Giao Q Phan, John M Kirkwood, Jessica C Hassel, Marlana Orloff, James Larkin, Jeffrey S Weber, Andrew J S Furness, Nikhil I Khushalani, Theresa Medina, Michael E Egger, Friedrich Graf Finckenstein, Madan Jagasia, Parameswaran Hari, Giri Sulur, Wen Shi, Xiao Wu, Amod A Sarnaik
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study. Journal for immunotherapy of cancer 10 (12) (2023)
Jason Chesney, Karl D Lewis, Harriet Kluger, Omid Hamid, Eric D Whitman, Sajeve Thomas, Martin Wermke, Mike Cusnir, Evidio Domingo-Musibay, Giao Q Phan, John M Kirkwood, Jessica C Hassel, Marlana Orloff, James Larkin, Jeffrey S Weber, Andrew J S Furness, Nikhil I Khushalani, Theresa Medina, Michael E Egger, Friedrich Graf Finckenstein, Madan Jagasia, Parameswaran Hari, Giri Sulur, Wen Shi, Xiao Wu, Amod A Sarnaik
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study. Journal for immunotherapy of cancer 10 (12) (2023)
Jason Chesney, Karl D Lewis, Harriet Kluger, Omid Hamid, Eric D Whitman, Sajeve Thomas, Martin Wermke, Mike Cusnir, Evidio Domingo-Musibay, Giao Q Phan, John M Kirkwood, Jessica C Hassel, Marlana Orloff, James Larkin, Jeffrey S Weber, Andrew J S Furness, Nikhil I Khushalani, Theresa Medina, Michael E Egger, Friedrich Graf Finckenstein, Madan Jagasia, Parameswaran Hari, Giri Sulur, Wen Shi, Xiao Wu, Amod A Sarnaik
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study. Journal for immunotherapy of cancer 10 (12) (2023)
Brian Thompson, Ann Strange, Carol M Amato, Jonathan Hester-McCullough, Amod A Sarnaik, Jeffrey S Weber, David M Woods
CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy. Journal of immunology (Baltimore, Md. : 1950) (2023)
Jason Chesney, Karl D Lewis, Harriet Kluger, Omid Hamid, Eric D Whitman, Sajeve Thomas, Martin Wermke, Mike Cusnir, Evidio Domingo-Musibay, Giao Q Phan, John M Kirkwood, Jessica C Hassel, Marlana Orloff, James Larkin, Jeffrey S Weber, Andrew J S Furness, Nikhil I Khushalani, Theresa Medina, Michael E Egger, Friedrich Graf Finckenstein, Madan Jagasia, Parameswaran Hari, Giri Sulur, Wen Shi, Xiao Wu, Amod A Sarnaik
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study. Journal for immunotherapy of cancer 10 (12) (2023)
MacLean S Hall, Jamie K Teer, Xiaoqing Yu, Holly Branthoover, Sebastian A Snedal, Madeline Rodriguez-Valentin, Luz Nagle, Ellen Scott, Benjamin I Schachner, Patrick Innamarato, Amy M Hall, Jamie Blauvelt, Carolyn J Rich, Allison D Richards, Jake Ceccarelli, T J Langer, Sean J Yoder, Matthew S Beatty, Cheryl A Cox, Jane L Messina, Daniel Abate-Daga, James J Mule, John E Mullinax, Amod A Sarnaik, Shari Pilon-Thomas
Neoantigen-specific CD4 + tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients. Journal for immunotherapy of cancer 11 (10) (2023)
MacLean S Hall, John E Mullinax, Cheryl A Cox, Amy M Hall, Matthew S Beatty, Jamie Blauvelt, Patrick Innamarato, Luz E Nagle, Holly Branthoover, Doris Wiener, Benjamin I Schachner, Alberto J Martinez, Allison D Richards, Carolyn J Rich, Marjorie Colón Colón, Michael J Schell, Jamie K Teer, Nikhil I Khushalani, Jeffrey S Weber, James J Mule, Vernon K Sondak, Shari A Pilon-Thomas, Amod A Sarnaik
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Amod A Sarnaik, Omid Hamid, Nikhil I Khushalani, Karl D Lewis, Theresa Medina, Harriet M Kluger, Sajeve S Thomas, Evidio Domingo-Musibay, Anna C Pavlick, Eric D Whitman, Salvador Martin-Algarra, Philippa Corrie, Brendan D Curti, Judit Oláh, Jose Lutzky, Jeffrey S Weber, James M G Larkin, Wen Shi, Toshimi Takamura, Madan Jagasia, Harry Qin, Xiao Wu, Cecile Chartier, Friedrich Graf Finckenstein, Maria Fardis, Joanne M Jeter, Jason A Chesney
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (24) (2021)
Patrick Innamarato, Sarah Asby, Jennifer Morse, Amy Mackay, MacLean Hall, Scott Kidd, Luz Nagle, Amod A Sarnaik, Shari Pilon-Thomas
Intratumoral Activation of 41BB Costimulatory Signals Enhances CD8 T Cell Expansion and Modulates Tumor-Infiltrating Myeloid Cells. Journal of immunology (Baltimore, Md. : 1950) 205 (10) (2020)